抗高血脂药物的研究进展

被引：47

作者：

侯晅

戴学文

房志仲

机构：

[1] 天津医科大学药学院

来源：

天津药学 | 2016年 / 28卷 / 04期

关键词：

抗高血脂药; 药物联用; 治疗;

D O I：

暂无

中图分类号：

R972.6 [];

学科分类号：

摘要：

血脂过高会严重危害人体健康,随着经济的发展,高血脂及其相关疾病患病率的日益增加已经不容忽视。通过分析高血脂的形成原因,列举其对心脑血管、血糖和肝功能等方面的影响,总结了现阶段高脂血症的预防及治疗方法,并根据药物的不同作用分类介绍,最后阐述了药物联用的重要性及合理应用。

引用

页码：59 / 64

页数：6

共 25 条

[1]

A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: The ezetimibe add-on to statin for effectiveness (EASE) trial [J].

Pearson, TA ;

Denke, MA ;

McBride, PE ;

Battisti, WP ;

Brady, WE ;

Palmisano, J .

MAYO CLINIC PROCEEDINGS, 2005, 80 (05) :587-595

[2]

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia [J].

Ballantyne, CM ;

Blazing, MA ;

King, TR ;

Brady, WE ;

Palmisano, J .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1487-1494

[3]

Inhibition of intestinal cholesterol absorption by ezetimibe in humans [J].

Sudhop, T ;

Lütjohann, D ;

Kodal, A ;

Igel, M ;

Tribble, DL ;

Shah, S ;

Perevozskaya, I ;

von Bergmann, K .

CIRCULATION, 2002, 106 (15) :1943-1948

[4]

Managing dyslipidemia in the high-risk patient.[J].Evan A Stein.The American Journal of Cardiology.2002, 5

[5]

Long-term safety and efficacy of a once-daily niacin / lovastatin formulation for patients with dyslipidemia * * A complete list of participants in the Research Group and Publication Committee appears in the Appendix ..[J].Moti L Kashyap;Mark E McGovern;Kathleen Berra;John R Guyton;Peter O Kwiterovich;Wayne L Harper;Phillip D Toth;Laurence K Favrot;Boris Kerzner;Stephen D Nash;Harold E Bays;Phillip D Simmons.The American Journal of Cardiology.2002, 6

[6]

实用内科学.[M].陈灏珠著.人民卫生出版社.2005,

[7]

依折麦布联合阿托伐他汀治疗原发性高脂血症临床疗效分析 [J].